Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-08-01

Clinical Trial Update: Gene Therapy for X-linked Severe Combined Immunodeficiency (SCID-X1) [NA]

View source ↗

Summary

A clinical trial update on a gene therapy for X-linked Severe Combined Immunodeficiency (SCID-X1). The current status and phase information are unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SCID-X1 gene therapy

Snippet

Sponsor: Great Ormond Street Hospital for Children NHS Foundation Trust | Conditions: X-linked Severe Combined Immunodeficiency | NA | Status: UNKNOWN